Skip to content
★ Sign in to follow
Biotron Limited logo

Biotron Limited Stock: price and insider trades · Australia

ISIN AU000000BIT4AU·Mcap A$5.6MHealth Care

Biotron Limited: what insiders have been doing

Biotron Limited is a Health Care company. Its directors and officers file their transactions with ASX. 5 insiders have disclosed 5 filings since 19 October 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Compared with its exchange (1,605 companies, median 4 filings), a count of 5 filings is above the norm.

Insider buying of Biotron Limited has been absent for the past year.

Other companies in the same sector with recent insider buying flagged by our signals: Vivos Inc and Anixa Biosciences Inc. This summary is built from ASX disclosures alone and does not predict where the share price will go.

Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2024

FY ended June 2024 · cache

A$0.00
Analyst consensus
·
Income statement
EBITDA-A$3.4M
Net income-A$3.4M-288.7% margin
Valuation
P/Book2.0x
Beta-0.64
Balance sheet & cash
Market capA$5.6M
Total debtA$7.1k
Free Cash Flow-A$3.6M
Profitability & ownership
ROE-87.4%
ROA-41.2%
% insiders37.6%
% institutions0.0%
Last declaration on 18 October 2026
Declarations5 total

5 of 5 declarations

About Biotron Limited

Biotron Limited is an Australian biopharmaceutical company focused on developing treatments for viral diseases and immune disorders. It is listed on the Australian Securities Exchange (XASX).